- Home
- ABBV vs PEP Comparison
ABBV vs PEP Comparison
Compare ABBV & PEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABBV | PEP |
|---|---|---|
| Founded | 2012 | 1898 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 375.7B | 203.2B |
| IPO Year | 2012 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ABBV | PEP |
|---|---|---|
| Price | $210.15 | $155.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 14 |
| Target Price | ★ $250.56 | $163.50 |
| AVG Volume (30 Days) | 4.6M | ★ 5.2M |
| Earning Date | 04-29-2026 | 04-16-2026 |
| Dividend Yield | 3.35% | ★ 3.65% |
| EPS Growth | ★ N/A | N/A |
| EPS | 2.36 | ★ 6.00 |
| Revenue | $61,160,000,000.00 | ★ $93,925,000,000.00 |
| Revenue This Year | $11.90 | $5.86 |
| Revenue Next Year | $8.13 | $3.22 |
| P/E Ratio | $87.35 | ★ $25.99 |
| Revenue Growth | ★ 8.57 | 2.25 |
| 52 Week Low | $168.54 | $127.60 |
| 52 Week High | $244.81 | $171.48 |
Technical Indicators
Market Signals| Indicator | ABBV | PEP |
|---|---|---|
| Relative Strength Index (RSI) | 45.43 | 48.75 |
| Support Level | $204.17 | $138.96 |
| Resistance Level | $212.45 | $158.05 |
| Average True Range (ATR) | 5.25 | 2.98 |
| MACD | 0.37 | 0.47 |
| Stochastic Oscillator | 45.17 | 71.79 |
Price Performance
Historical ComparisonAbout ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
About PEP PepsiCo Inc.
PepsiCo is a global leader in snacks and beverages, owning well-known household brands including Pepsi, Mountain Dew, Gatorade, Lay's, Cheetos, and Doritos, among others. The company dominates the global savory snacks market and also ranks as the second-largest beverage provider in the world (behind Coca-Cola) with diversified exposure to carbonated soft drinks, or CSD, as well as water, sports, and energy drink offerings. Convenience foods account for approximately 58% of its total revenue, with beverages making up the rest. Pepsi owns the bulk of its manufacturing and distribution capacity in the US, but uses bottlers overseas for beverages. International markets made up 40% of both total sales and operating profits in 2024.